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Summary
X inactivation silences most but not all of the genes on
one of the two X chromosomes in mammalian females.
The human X chromosome preserves its activation
status when isolated in rodent/human somatic-cell hy-
brids, and hybrids retaining either the active or inactive
X chromosome have been used to assess the inactivation
status of many X-linked genes. Surprisingly, theX-linked
gene for human tissue inhibitor of metalloproteinases
(TIMP1) is expressed in some but not all inactive X-
containing somatic-cell hybrids, suggesting that this gene
is either prone to reactivation or variable in its inacti-
vation. Since many genes that escape X inactivation are
clustered, we examined the expression of four genes
(ARAF1, ELK1, ZNF41, and ZNF157) within ∼100 kb
of TIMP1. All four genes were expressed only from the
active X chromosome, demonstrating that the factors
allowing TIMP1 expression from the inactive X chro-
mosome are specific to the TIMP1 gene. To determine
if this variable inactivation of TIMP1 is a function of
the hybrid-cell environment or also is observed in human
cells, we developed an allele-specific assay to assess
TIMP1 expression in human females. Expression of two
alleles was detected in some female cells with previously
demonstrated extreme skewing of X inactivation, indi-
cating TIMP1 expression from the inactive chromosome.
However, in other cells, no expression of TIMP1 was
observed from the inactive X chromosome, suggesting
that TIMP1 inactivation is polymorphic in human
females.
Introduction
X-chromosome inactivation is the transcriptional si-
lencing of one of the two X chromosomes in mammalian
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females, which achieves dosage compensation for X-
linked gene products, between males and females (Lyon
1961). Within each cell, one X chromosome is chosen,
early in development, to be inactivated, and this epi-
genetic silencing is maintained in a clonal fashion
throughout subsequent somatic-cell divisions (Davidson
et al. 1963). The exceptional stability of this silencing
is demonstrated by tumors that maintain clonal X in-
activation, with only one allele expressed after 1100 cell
divisions (Linder and Gartler 1965). The inactive X
chromosome is hypermethylated and nuclease insensitive
and has delayed replication timing compared with the
active chromosome (Gartler and Goldman 1994). XIST
is expressed only from the inactive X chromosome, and
the XIST RNA is localized to the inactive X chromosome
(Brown et al. 1992). The histones associated with the
inactive X chromosome tend to be hypoacetylated (Jep-
pesen and Turner 1993), and there is preferential asso-
ciation of histone macroH2A1 (Costanzi and Pehrson
1998). It is believed that these factors contribute, either
alone or cooperatively, to the stable silencing of the
chromosome.
Although the majority of X-linked genes are believed
to be subject to the dosage-compensation mechanism of
X inactivation, there are numerous genes that escape this
silencing and that are expressed from both the active
and inactive X chromosomes (Disteche 1995). The X-
inactivation status of human X-linked genes has been
determined in a number of ways. Direct evidence for X
inactivation includes mosaic expression of X-linked gene
products in heterozygous females or equal levels of gene
expression in males and females (reviewed in Brown and
Willard 1993). Rodent/human somatic-cell hybrids re-
tain the X-inactivation status of their human X chro-
mosome (Migeon 1972) and are therefore frequently
used to assess the expression state of individual genes
from the active or inactive X chromosome (Brown et al.
1997; Esposito et al. 1997). Previous analyses of the
inactivation status of X-linked genes, using somatic-cell
hybrids, have been concordant with prior evidence for
X-inactivation status (Migeon 1972; Schneider-Gadicke
et al. 1989; Fisher et al. 1990). Surprisingly, some genes
are expressed in some but not all of the inactive X-
containing hybrids (Brown et al. 1997). One of the
genes showing this variable expression is the human tis-
sue inhibitor of metalloproteinases-1 (TIMP1 [MIM
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305370]), one member of a family of proteins that in-
hibit metalloproteinases by binding to their active sites
(Denhardt et al. 1993).
Genes expressed from both the inactive and active X
chromosomes are often located in clusters along the X
chromosome, suggesting a regional basis for the estab-
lishment of X-inactivation patterns (Disteche 1995;Mil-
ler and Willard 1998). Most of the ∼30 genes known
to escape inactivation are located either in the pseu-
doautosomal and flanking regions of distal Xp or in the
proximal short arm of the X chromosome. These regions
of the inactive X chromosome behave more like the ac-
tive chromosome, replicating earlier and retaining more
acetylation of histones than does the remainder of the
inactive X chromosome (Schempp and Meer 1983; Jep-
pesen and Turner 1993). Human TIMP1 is in a gene-
rich region containing ARAF1, ELK1, ZNF41, and
ZNF157 within 100 kb (Coleman et al. 1994; Knight
et al. 1994; Derry et al. 1995; Brandau et al. 1998). We
therefore assessed whether this entire region was ex-
pressed from the inactive X chromosome, by examining
the expression of these genes flanking TIMP1.
Expression from the inactive X chromosome may also
be the result of reactivation of a gene normally subject
to X inactivation. Reactivation of the entire inactive X
chromosome occurs naturally during oogenesis, and sin-
gle genes have been shown to reactivate with age in mice.
Experimentally, reactivation of single genes or regions
of the X chromosome can be increased by cell fusion
and/or treatment with demethylating agents (reviewed
in Gartler and Goldman 1994). The maintenance of X
inactivation does appear to be less stringent in rodent/
human hybrids compared with human fibroblasts (Ka-
han and DeMars 1975; Ellis et al. 1987), and the ob-
served expression of TIMP1 from the inactive X chro-
mosome may be due to the hybrid-cell environment. To
determine if TIMP1 expression from the inactive X chro-
mosome occurs in human cells as well as in hybrid cells,
an expressed polymorphism in the TIMP1 gene was
identified and was used to assess expression in hetero-
zygous female cells previously shown to have extreme
skewing of X inactivation.
Material and Methods
Somatic-Cell Hybrids
Human/rodent somatic-cell hybrids were kindly pro-
vided by H. F. Willard (CaseWestern ReserveUniversity)
or S. Hansen (University of Washington) or were gen-
erated by somatic-cell fusion as described elsewhere
(Hansen et al. 1988; Brown and Willard 1989; Willard
et al. 1993). Fourteen independent hybrids were used to
study the expression of genes in the region surrounding
TIMP1. Six hybrids retained an active X chromosome,
and eight hybrids had an inactive X chromosome, in-
cluding the four inactive X-containing hybrids that dis-
played TIMP1 expression. The hybrids contained entire
human X chromosomes—except for t81-az1D, which
had a shortened human X chromosome that was deleted
for the majority of the long arm (Brown et al. 1991).
There were no autosomes in common among all of the
inactive X-containing hybrids that expressed TIMP1.
Reverse Transcriptase–PCR Analysis (RT-PCR)
Cells were harvested at confluence with trypsin-EDTA
(0.25%). RNA was prepared by means of a standard
acid-guanidinium extraction protocol (Chomczynski
and Sacchi 1987). RNA concentration was determined
spectrophotometrically, and 2–5 mg of RNAwas reverse-
transcribed with Moloney murine leukemia virus reverse
transcriptase (GIBCO-BRL), by random hexamer prim-
ing (Brown et al. 1990). The PCR primers used to am-
plify products for the genes at Xp11.23 are listed in table
1, with the corresponding amplification conditions. PCR
was performed by means of GIBCO-BRL Taq polymer-
ase, 1 mM primer, 20 mM of each dNTP, and 100–200
mg of template, in a Techne thermocycler. As controls,
all primer pairs were shown to be human specific, with
no amplification of mouse and hamster cDNA, and all
cDNAs were demonstrated to be free of DNA contam-
ination, by amplification of RNA without reverse tran-
scription, by means of the XIST 1:2r primers that am-
plify DNA (Brown et al. 1992). The presence or absence
of XIST expression, which is transcribed only from the
inactive X chromosome, confirmed the inactivation
status of the human X chromosome in the hybrids and
demonstrated the presence of amplifiable cDNA in the
inactive X–containing hybrids.
TIMP1 Polymorphism Assay
To identify expressed polymorphisms, human TIMP1
cDNA (EMBL A10416 [EMBL Outstation, European
Bioinformatics Institute]) was compared with all se-
quences in GenBank (version 101), by means of the
BLASTN program (BLAST). Of 17 sequences for this
region, 4 contained a C instead of a T at base pair 434
in exon 5. A constant primer (CA1) and a pair of allele-
specific oligonucleotide primers were designed with the
variant base at the 3′ end of the second primer. PCR
conditions were optimized to allow allele-specific am-
plification (table 1 and fig. 2). The primers do not am-
plify mouse DNA or mouse cDNA and give a smaller
product when amplifying human cDNA, because they
span an intron. The amplification products were visu-
alized on 2% agarose gels stained with ethidium bro-
mide. The female cells were shown to have extreme
skewing of X inactivation (190% one allele active), by
one of several assays that rely on either an expressed
polymorphism (XIST [Rupert et al. 1992]) or methyl-
ation differences near a polymorphic site (androgen re-
Table 1
PCR Primers and Amplification Conditions
Gene Primersa
Product Size
(bp) PCR Conditions Reference
TIMP1 C1A: CCCTGATGACGAGGTCGGAA
C1B: AGATCCAGCGCCCAGAGAGA
147 1.5 mM MgCl2; 94C, 1 min; 54C, 1 min; 72C, 2 min (30 cycles) Brown et al. (1990)
ARAF1 B: TCAGCAAAATCTCCAGCAAC
3: TGGAGATGGAGGAGCTCCCA
482 2.5 mM MgCl2; 94C, 1 min; 60C, 1 min; 72C, 2 min (40 cycles) Brown et al. (1997)
ELK1 A: GGACCTAGAGCTTCCACTCA
B: AGAGCATGGATGGAGTGACC
388 1.5 mM MgCl2; , 6% DMSO,
b 94C, 1 min; 56C, 1 min; 72C, 2 min (35 cycles) Brown et al. (1997)
ZNF41 A: TTTTAGAAGAACTGTGGCAAG
B: CTCAGGATGAATTTTCTGATG
300 1.0 mM MgCl2; 94C, 1 min; 54C, 1 min; 72C, 2 min (40 cycles) Derry et al. (1995)
ZNF157 A: GCCTCTCACTGAAGACTTC
B: AGCAAGACATGAACAGCCC
280 2.0 mM MgCl2; 94C, 1 min; 58C, 1 min; 72C, 2 min (35 cycles) Derry et al. (1995)
XIST C9-4: AGCTCCTCGGACAGCTGTAA
C7B2 (revised): CTCCAGATAGCTGGCAACC
240 1.5 mM MgCl2; 94C, 1 min; 54C, 1 min; 72C, 2 min (30 cycles) Duncan et al. (1993)
XIST 1:2r (DNA) 3′: GAAGTCTCAAGGCTTGAGTTAGAAG
5′: TTGGGTCCTCTATCCATCTAGGTAG
220 1.5 mM MgCl2; 94C, 1 min; 54C, 1 min; 72C, 2 min (30 cycles) Brown et al. (1992)
TIMP-C CA1: GGGTTCCAAGCCTTAGGGGA
C: CTGTTCCAGGGAGCCACG
385 (DNA), 183 (cDNA) 1.5 mM MgCl2; 94C, 1 min; 58C, 30 s; 72C, 1 min (30 cycles)
TIMP-T CA1: GGGTTCCAAGCCTTAGGGGA
C: CTGTTCCAGGGAGCCACA
385 (DNA), 183 (cDNA) 1.5 mM MgCl2; 94C, 1 min; 58C, 30 s; 72C, 1 min (30 cycles) EMBL Outstation, European
Bioinformatics Institutec
a Underlining denotes primers newly designed on the basis of the sequence provided by the reference cited; other primers are directly from the references listed.
b Dimethyl sulfoxide.
c Accession number A10416.
702 Am. J. Hum. Genet. 65:699–708, 1999
Table 2
Expression of the Five Genes in Various Somatic Cell Hybrids
HYBRID CELL LINEa
EXPRESSIONb
TIMP1 ARAF1 ELK1 ZNF41 ZNF157 XIST
Active X:
AHA-11aB1      
t60-12      
A23-1aC15      
tHM-34-2A-41B      
GM06318Da      
CHO-01416-Ma      
Inactive X:
t11-4Aaz5      
t48-1a-1Daz4a      
tHM-34-2A-3az1a      
X8-6T2S1a      
t86-B1maz1b-3a      
t81-az1D      
t75-2maz34-1a      
CHO–01416-O7a      
a Hybrid with a hamster parental line.
b A plus sign () denotes presence of expression, and a minus sign () denotes absence of expression.
ceptor [Allen et al. 1992] or fragile X [Carrel andWillard
1996]). The same sample of cells was used in the TIMP1
polymorphism assay and to determine the extent of
skewing for X inactivation. Causes for the skewed in-
activation patterns included X-autosome translocations
(in 09, GM01813, and GM02859A); X-chromosome re-
arrangements (in SA70, described by Leppig et al. 1993);
X-linked disease carriers (e.g., Wiskott-Aldrich syn-
dome, in 07); XIST mutations (in HSC593 and 60 [both
of which are from a single female], described by Rupert
et al. 1992; Plenge et al. 1997); or lymphoblasts derived
from normal females (in GM07059 and GM07348),
which may have become clonal either during derivation
or in culture (Migeon et al. 1988b).
Results
Expression of TIMP1 and Flanking Genes in Hybrid
Cells
Expression of human TIMP1 was examined in six
active X– and eight inactive X–containing human/rodent
somatic-cell hybrids. cDNA was amplified by RT-PCR
with primers for TIMP1, and amplification of TIMP1
was observed in all six active-X hybrids, as well as in
four of eight inactive-X hybrids (table 2). To determine
if the expression from the inactive X chromosome ex-
tended beyond TIMP1, we analyzed the expression of
genes surrounding TIMP1, within the gene-rich region
of Xp11.23 (fig. 1A) (Coleman et al. 1994; Knight et al.
1994; Derry et al. 1995; Brandau et al. 1998). RT-PCR
was performed with primers for TIMP1, ARAF-1 (a raf-
related gene located 20 kb distal to TIMP1), ELK1 (a
transcription factor and proto-oncogene 50 kb proximal
to TIMP1), and two zinc-finger genes (ZNF41 and
ZNF157), which are located !100 kb from TIMP1. Al-
though TIMP1 is found within intron 5 of SYN1 (Derry
and Barnard 1992), SYN1 expression was not examined,
since this tissue-specific gene is not expressed in fibro-
blasts (Yang-Feng et al. 1986) and, therefore, was not
expected to be expressed at significant levels in the so-
matic-cell hybrids. As shown in figure 1B and as sum-
marized in table 2, ARAF1, ELK1, ZNF41, and
ZNF157 were expressed only in hybrids that retained a
human active X chromosome. No expression of these
genes was observed in the inactive X–containing hybrids,
including those in which TIMP1 expression had been
detected.
Expression of TIMP1 from the Inactive X Chromosome
in Human Cells
When TIMP1 cDNA sequences in the GenBankDNA-
sequence repository were compared, a polymorphism
was found, eliminating the need for the traditional labor-
intensive methods of mutation detection and sequencing.
The polymorphism is a TrC base-pair change in exon
5, part of the coding region, but the transition is silent,
because it is the third base of a codon and both alleles
code for phenylalanine. This polymorphism has been
independently identified (Hardcastle et al. 1997). The
base-pair difference was exploited to develop a PCR-
based assay (fig. 2A) to analyze TIMP1 expression in
human females. By means of a constant primer and two
allele-specific primers, conditions were optimized to pro-
vide amplification of the allele matching the primer,
without spurious amplification of the opposite allele.
The sensitivity of the assay was determined by mixing
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Figure 1 Expression analysis of genes in Xp11.23. A, Schematic
map of genes flanking TIMP1. ZNF41 is present in a YAC spanning
the region represented by the arrow; however, the unbroken portion
of the arrow represents the most likely area for ZNF41, since an
overlapping YAC that was negative for ZNF41 was shown to be de-
leted in this region (Brandau et al. 1998). B, Products from amplifi-
cation of cDNA derived from the hybrids, listed with human-specific
primers for the genes shown. Hybrids retaining the active X chomo-
some (Xa) or inactive X chromosome (Xi) are denoted as follows (num-
bers denote lanes): 1 = A23-1aC15; 2 = tHM-34-2A41B; 3 = t11-
4Aaz5; 4 = t48-1a-1Daz4a; 5 = tHM-34-2A-3az1a; 6 = t75-2maz34-
1a; 7 = t86-B1maz1b-3a; 8 = CHO-01416-07.
the DNA from homozygous females in different ratios
(fig. 2B), and an allele present in 10% of the total
DNA was consistently detected (fig. 2B). In a sample
of unrelated human females, males, cell lines, and so-
matic-cell hybrids, the different alleles had almost equal
frequencies (98 C and 100 T, of 198 X chromosomes
tested).
Female cell lines with previously demonstrated ex-
treme skewing of X inactivation were used to assess ex-
pression of TIMP1 from the inactive X chromosome. As
shown schematically in figure 2, if TIMP1 were subject
to inactivation, only the one allele on the active X chro-
mosome would be expressed. Expression of both alleles
in a female with extreme skewing of X inactivation
would demonstrate that TIMP1 is also being expressed
from the inactive X chromosome. Examples of female
cells with and without TIMP1 expression from the in-
active X chromosome are shown in figure 2C: panels 1
and 2 show the results of analysis of homozygous fe-
males, demonstrating the specificity of the assay, and
panels 3–6 show results obtained from heterozygous fe-
males, as shown by the presence of two alleles when
DNA is amplified. When cDNA was amplified, only one
allele was observed in GM07059 and female 09, dem-
onstrating that TIMP1 was only expressed from the ac-
tive X chromosome in these cells. However, two TIMP1
alleles were detected after amplification of cDNA from
HSC593 and 60 and from female 07, showing that
TIMP1 was expressed from both X chromosomes and
was not subject to X inactivation in these cells. The
extreme (190%) skewing of X inactivation for these fe-
males is shown in figure 2D. For sample 4 in figure 2D,
the female was heterozygous for androgen receptor, as
shown by the presence of two alleles in uncut DNA.
Amplification after digestion with the methylation-sen-
sitive enzyme HpaII, which cuts DNA from the unme-
thylated, active X chromosome, shows predominantly
the upper band. A very faint band is seen for the other
allele, suggesting either a very small proportion of cells
with the other X chromosome active or incomplete di-
gestion; however, this band is of much lower intensity
than the weaker band seen in TIMP1 cDNA. For sample
6 in figure 2D, the female was heterozygous for XIST,
as has been described elsewhere (Rupert et al. 1992;
Plenge et al. 1997). In cDNA, only one allele is amplified,
establishing that the same X chromosome is active in all
cells. In summary, TIMP1 expression was seen from the
inactive X chromosome in three individuals, whereas no
expression from the inactive X chromosome was de-
tected in five females (table 3).
Discussion
To gain insight into the mechanisms involved in the
maintenance of X inactivation, TIMP1 expression from
the inactive X chromosome was analyzed in somatic-cell
hybrids and females with extreme skewing of X inac-
tivation. It had previously been shown that TIMP1 was
expressed in two of five inactive-X hybrids (Brown et
al. 1997), and the present study examined four addi-
tional inactive-X hybrids, including ones derived from
hamster (table 2). When both studies are combined, four
of nine inactive-X hybrids expressed TIMP1, and the
variable inactivation of TIMP1 was not confined to one
rodent parental line. We postulated that the TIMP1 ex-
pression from the inactive chromosome might be re-
stricted to the hybrid system, since reactivation (sporadic
expression from the inactive X chromosome) of other
genes is observed at an elevated frequency in hybrids
(Kahan and DeMars 1975; Gartler and Goldman 1994).
TIMP1 expression from the inactive X chromosomewas
therefore investigated by examination of heterozygous
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Figure 2 TIMP1 polymorphism assay and results. A, Schematic outline of the TIMP1 polymorphism assay. Oligonucleotide primers were
designed and optimized to provide allele-specific amplification. We analyzed females with extreme skewing of X inactivation so that the same
X chromosome would be active in all cells. DNA was first tested to find heterozygous females. In these informative females, cDNA was then
amplified. The resulting products differ, in size, between DNA and cDNA, since the primers span a small intron. In this diagram, the active X
chromosome is shown to have the C allele, and the inactive X chromosome has the T allele. If only the C allele was amplified in cDNA, there
was no TIMP1 expression from the inactive X chromosome. If both the C and T alleles were seen in cDNA, TIMP1 was expressed from both
X chromosomes. B, Specificity of the allele-specific primers, as demonstrated by the amplification of only one allele in the homozygous samples
(end lanes). When these DNA samples were mixed in the various proportions as listed, 10% of one allele could be detected in the presence of
the other allele. C, Results for females with extreme skewing of X inactivation, demonstrated by other assays (numbers denote gels): 1 = female
homozygous for C (GM07023); 2 = female homozygous for T (AG); 3 = heterozygous female, TIMP1 inactivated (09); 4 = heterozygous female,
TIMP1 expressed from both X chromosomes (07); 5 = heterozygous female, TIMP1 inactivated (GM07059); 6 = heterozygous female, TIMP1
expressed from both X chromosomes. L = lymphoblast (HSC593); F = fibroblast (60). D, Confirmation of X-inactivation patterns (190%
skewing), for panels 4 and 6. For female 07 (gel 4), androgen-receptor methylation assay is shown. Both alleles are seen in uncut DNA. After
digestion with the methylation-sensitive enzyme HpaII, amplification of the bottom allele is essentially eliminated, demonstrating that it is
unmethylated—and therefore active—in the majority of the cells. For female HSC593 (L) and 60 (F) (gel 6), the results of XIST allele-specific
PCR amplification are shown. Both alleles are present in DNA, but only one allele is amplified in cDNA, showing that the same X chromosome
is inactive in all cells.
females with extreme skewing of X inactivation. These
females had the same X chromosome active in all cells,
so that the presence of two alleles in the cDNA is in-
dicative of expression from the active X chromosome as
well as from the second, inactive X chromosome.TIMP1
expression from the inactive X chromosome was ob-
served in three of the eight informative human females
and cell lines analyzed (table 3). This frequency is similar
to that observed in the hybrids, and, in the two cases in
which human cell lines and the inactive X–containing
hybrids derived from them were examined, the expres-
sion from the inactive X chromosome was concordant,
providing further evidence that the hybrid system ac-
curately reflects expression of X-linked genes in humans.
Therefore, other genes expressed variably in the hybrid
system (Brown et al. 1997) may also be polymorphic in
humans. Indeed, polymorphic inactivation does not
seem to be limited to the TIMP1 gene, since variable
inactivation has been described in females with cho-
roideremia (Carrel and Willard, in press). Therefore,
TIMP1 may belong to a new class of X-linked genes
that are subject to inactivation in some individuals but
that escape inactivation in others.
We do not yet know the mechanism leading to poly-
morphic expression from the inactive X chromosome.
The variability could involve a feature inherent in the
TIMP1 gene, another X-linked feature that functions in
the cis-limited inactivation process, or some trans-acting
factor. Expression of TIMP1was observed from inactive
X chromosomes with both the C and T alleles, sug-
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Table 3





09 Peripheral blood CT C
07 Peripheral blood CT CT
GM07059 Cultured lymphoblasts CT C
GM07348 Cultured lymphoblasts CT C
SA70 Cultured lymphoblasts CT T
HSC593 Cultured lymphoblasts CT CT
60 Cultured fibroblasts CT CT
GM02859 Cultured fibroblasts CT T
GM01813 Cultured fibroblasts CT CT
gesting that one TIMP1 allele is not predisposed to ex-
pression from the inactive X chromosome. Imprinting
has been shown to be polymorphic among individuals,
with monoallelic expression in some individuals and
biallelic expression in others (Jinno et al. 1995; Gian-
noukakis et al. 1996). It is possible that similar trans-
acting factors are involved in the biallelic expression of
TIMP1 and imprinted genes, since X inactivation and
imprinting may involve similar epigenetic mechanisms
of silencing (Tilghman and Willard 1995). Imprinting
has also been observed to change between developmen-
tal stages (Jinno et al. 1995) and tissues (Ohlsson et al.
1994), but the expression of TIMP1 from the inactive
X chromosome was not limited to one cell type in the
one individual examined, since both lymphoblasts
(HSC593) and fibroblasts (60) of that individual had
biallelic expression. Furthermore, if X-linked or trans-
acting factors were involved in this variable expression
from the inactive X chromosome, then all the genes sus-
ceptible to expression from the inactive X chromosome
would be expected to be expressed in the same inactive-
X hybrids, which has not been observed (Brown et al.
1997).
The variability of X inactivation could arise through
either the loss of maintenance (“reactivation”) or an
initial “escape” from inactivation. X inactivation is
generally stable in somatic cells, with reactivation oc-
curring only at very low frequencies—for example,
!108 for HPRT (Kahan and DeMars 1975), which is
much below the 30%–50% frequency seen for TIMP1.
The fact that TIMP1 expression from the inactive X
chromosome was concordant among different tissues
in the same individual provides evidence for an early
choice of expression status. Genes escaping inactivation
are often found in clusters, which implicates regional
features permitting their expression (Gartler and Gold-
man 1994; Miller and Willard 1998), but we deter-
mined that variable expression from the inactive X
chromosome was limited to the TIMP1 gene. It is pos-
sible that the distinction between genes escaping or sub-
ject to X inactivation may not be mechanistic but,
rather, temporal. The mouse gene Smcx escapes X in-
activation in adult tissues, but it is initially inactivated
in development (Lingenfelter et al. 1998). Genes that
“escape” inactivation may be reactivated early in de-
velopment, whereas other genes may rarely reactivate
and therefore appear fully inactivated. For genes such
as TIMP1, which show variable expression from the
inactive X chromosome, the timing of reactivation may
occur between these extremes. In mice, reactivation of
several genes has been shown to increase with age (Cat-
tanach 1974; Wareham et al. 1987; Brown and Rastan
1988), but long-term culture of inactive X–containing
hybrids shows no evidence for reactivation of TIMP1.
An age-related increase in reactivation frequency has
not been observed for the human HPRT gene (Migeon
et al. 1988a), but HPRT may be strongly silenced and
therefore may require a period longer than a human
life span before it is reactivated. Elevated reactivation
frequencies are seen in marsupials and extraembryonic
tissues that do not have hypermethylation of their in-
active X chromosomes (Migeon et al. 1985; Kaslow
and Migeon 1987), indicating that methylation may be
critical for the stability of X inactivation. The relatively
low CpG density of the TIMP1 promoter may therefore
be contributing to its expression from the inactive X
chromosome. This argument of reactivation timing
suggests that maintenance of silencing is the critical
determinant of expression patterns for X-linked genes,
not the initial inactivation event. It will be interesting
to analyze the epigenetic factors normally associated
with the inactive X chromosome, such as methylation
and chromatin structure, to see if they differ when
TIMP1 is expressed from the inactive chromosome.
Whatever the mechanism allowing TIMP1 expression
from the inactive X chromosome, we anticipate that
expression levels will vary between individuals, since
TIMP1 inactivation status is not consistent. TIMP1
therefore seems to be an exception to X inactivation
maintaining gene dosage between males and females
(Lyon 1962). TIMP1 expression levels may follow a con-
tinuum dependent on whether a female has random in-
activation and whether both of her X chromosomes ex-
press TIMP1 when they are inactivated. Furthermore,
the amount of TIMP1 expressed from the inactive X
chromosome may be lower than that expressed from the
active X chromosome, as has been shown for several
genes expressed from the inactive X chromosome (Mig-
eon et al. 1982; Carrel et al. 1996; Sheardown et al.
1996). It is possible that dosage is controlled at the level
of translation, so the TIMP1 protein may not vary re-
gardless of RNA levels. However, if the TIMP1 protein
is elevated, then the variable expression may be clinically
significant, since TIMP1 and the metalloproteinases that
it inhibits are widely expressed proteins involved in a
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variety of processes. Women with an increased level of
TIMP1 might be insulated from conditions arising from
decreased TIMP1, including rheumatoid arthritis, but
might also be susceptible to other disorders, such as liver
fibrosis (Denhardt et al. 1993; Gomez et al. 1997). In
addition to identifying possible phenotypic variations
and disease susceptibilities due to the polymorphic X
inactivation of the TIMP1 gene, further analysis of this
variability will provide a window to study the epigenetic
changes underlying the maintenance of X inactivation.
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